Erdafitinb in patients with FGFR-altered tumors: Results from the NCI-COG Pediatric MATCH trial arm B (APEC1621B).
Alice A. Lee(Palo Alto University), D. Williams Parsons(Baylor College of Medicine), Lauren Saguilig(Children's Oncology Group), Sinchita Roy‐Chowdhuri(The University of Texas MD Anderson Cancer Center), Joel M. Reid(Children's Hospital of Philadelphia), David R. Patton(National Cancer Institute), Nita L. Seibel(National Cancer Institute), Elizabeth Fox(Children's National), Katherine A. Janeway(Harvard University), Alexander J. Chou(Cornell University), Alok Jaju(Lurie Children's Hospital), Todd A. Alonzo(University of Southern California), Brent Coffey(National Cancer Institute), James V. Tricoli(National Cancer Institute), Stacey L. Berg(University of Twente), Naoko Takebe(National Institutes of Health), Douglas S. Hawkins(Seattle Children's Hospital), P. Mickey Williams(Leidos (United States)), Margaret Mooney(National Cancer Institute), Jin Piao(Children's Oncology Group)
Cited by 18
Related Papers
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
|Science|2006|3.2k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|1999|1.2k